LH Blood Test: When to Order, Normal Ranges, and What Results Mean

Medical lab testing image for LH Blood Test: When to Order, Normal Ranges, and What Results Mean

At a glance

  • Full name / Luteinizing hormone, a glycoprotein produced by the anterior pituitary
  • Sample type / Serum blood draw, fasting not required
  • Timing / Early morning preferred; cycle days 2 to 4 in premenopausal women
  • Normal range (adult men) / 1.8 to 8.6 IU/L
  • Normal range (follicular phase women) / 1.9 to 12.5 IU/L
  • Normal range (midcycle surge) / 8.7 to 76.3 IU/L
  • Normal range (postmenopausal women) / 15.9 to 54.0 IU/L
  • Turnaround time / Typically 1 to 2 business days
  • Commonly ordered with / FSH, estradiol, testosterone, prolactin
  • Cost without insurance / Approximately $30 to $75 at most commercial labs

What Is LH and Why Does It Matter?

Luteinizing hormone is a gonadotropin secreted by gonadotroph cells in the anterior pituitary gland. It acts directly on the gonads: in men, LH stimulates Leydig cells to produce testosterone; in women, it triggers ovulation and supports the corpus luteum during the luteal phase. Without adequate LH signaling, reproductive function stalls.

LH does not operate alone. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in a pulsatile pattern, which tells the pituitary how much LH (and follicle-stimulating hormone, or FSH) to secrete 1. This hypothalamic-pituitary-gonadal (HPG) axis functions as a feedback loop. When testosterone or estradiol levels drop, GnRH pulses increase, and LH rises. When sex steroids are sufficient, LH falls. A single LH value therefore tells you something about the entire axis, not just the pituitary. That makes it one of the most cost-effective tests in reproductive endocrinology.

The clinical utility of LH stretches across disciplines. Reproductive endocrinologists use it to time ovulation. Urologists and men's health specialists rely on it to classify hypogonadism. Pediatric endocrinologists check it when precocious or delayed puberty is suspected 2. One hormone, many clinical questions.

When Should a Clinician Order an LH Test?

The most common reason to order an LH test is to determine whether low sex hormone levels originate in the gonads or in the brain. This distinction changes treatment entirely.

Suspected male hypogonadism. The Endocrine Society's 2018 clinical practice guideline recommends measuring total testosterone first, confirmed by a repeat morning sample 3. If testosterone is confirmed low (below 300 ng/dL on two occasions), LH and FSH should follow. An elevated LH (above 9.4 IU/L in most assays) with low testosterone points to primary hypogonadism, meaning the testes themselves are failing. A low or inappropriately normal LH with low testosterone points to secondary (central) hypogonadism, meaning the pituitary or hypothalamus is the problem 3. The Endocrine Society guideline states: "Measurement of serum LH and FSH levels can help distinguish primary from secondary hypogonadism and guide further diagnostic evaluation" 3.

Female infertility workup. The American Society for Reproductive Medicine (ASRM) recommends day-3 LH and FSH as part of the baseline fertility evaluation 4. An LH-to-FSH ratio greater than 2:1 on day 3 raises suspicion for polycystic ovary syndrome (PCOS), though this finding alone is not diagnostic 5.

Ovulation confirmation. Serial LH measurements or urinary LH kits detect the midcycle surge that precedes ovulation by 24 to 36 hours. In a study of 696 cycles, the LH surge occurred a median of 1.1 days before ultrasound-confirmed ovulation 6.

Menopause confirmation. An FSH above 30 IU/L combined with an elevated LH in a woman with 12 months of amenorrhea confirms menopause, per the North American Menopause Society 7.

Pituitary pathology. When a clinician suspects a pituitary adenoma, craniopharyngioma, or infiltrative disease, LH is part of the anterior pituitary panel. A low LH with low sex steroids, combined with deficiencies in other pituitary axes, suggests hypopituitarism 8.

Pediatric evaluation. Central precocious puberty shows elevated LH for age, often confirmed with a GnRH stimulation test. Delayed puberty with persistently low LH may indicate hypogonadotropic hypogonadism 9.

How to Interpret Normal LH Ranges

Reference ranges for LH shift dramatically by sex, age, and menstrual cycle phase. Context determines everything.

For adult men, most laboratories report a reference range of 1.8 to 8.6 IU/L 10. LH values in men do not fluctuate as sharply as in women, but pulsatile secretion means a single sample can vary by 20% to 30% from one hour to the next 1. Drawing blood in the early morning (between 7:00 and 10:00 AM) reduces this variability because testosterone's diurnal peak exerts the most consistent feedback at that time.

For premenopausal women, ranges depend on the cycle phase. During the early follicular phase (days 2 to 4), normal LH runs 1.9 to 12.5 IU/L. At the midcycle surge, LH can spike to 8.7 to 76.3 IU/L. The luteal phase typically shows 0.5 to 16.9 IU/L 10. Any interpretation without knowing cycle day is unreliable.

Postmenopausal women show persistently elevated LH, generally 15.9 to 54.0 IU/L, reflecting the loss of ovarian estradiol feedback 7.

Children before puberty normally have LH values below 0.3 IU/L in girls and below 0.5 IU/L in boys. A prepubertal LH above 0.3 IU/L in a girl younger than 8 or a boy younger than 9 warrants investigation for precocious puberty 9.

What Does a High LH Level Mean?

A high LH reading signals that the pituitary is working hard to compensate for low sex steroid output from the gonads. The clinical term for this pattern is hypergonadotropic hypogonadism.

In men, elevated LH (above approximately 9 IU/L) with low testosterone indicates primary testicular failure. Causes include Klinefelter syndrome (47,XXY), which affects roughly 1 in 660 males and remains the most common chromosomal cause of primary hypogonadism 11. Other causes: prior chemotherapy, radiation, orchitis, or bilateral cryptorchidism. A European Male Ageing Study (EMAS) analysis of 3,369 men aged 40 to 79 found that 2.0% had elevated LH with low total testosterone, classifying them as having compensated or overt primary hypogonadism 12.

In premenopausal women, a persistently elevated LH (especially with a high LH:FSH ratio) is often associated with PCOS. The Rotterdam criteria do not require LH for PCOS diagnosis, but the American Association of Clinical Endocrinology (AACE) notes that "an elevated LH:FSH ratio supports, though does not confirm, a PCOS diagnosis" 5. Other causes of high LH in premenopausal women include premature ovarian insufficiency (POI), where both LH and FSH rise above 25 IU/L on two samples taken at least four weeks apart 13.

In postmenopausal women, elevated LH is expected and typically does not require action.

What Does a Low LH Level Mean?

Low LH with low testosterone or estradiol points upstream, to the hypothalamus or pituitary. This is hypogonadotropic (secondary) hypogonadism, and its causes are fundamentally different from primary gonadal failure.

The most common cause in clinical practice is exogenous testosterone or anabolic steroid use. Supraphysiologic testosterone suppresses GnRH pulses, which drops LH (often to <0.5 IU/L) and shuts down spermatogenesis 14. Men presenting with infertility and suppressed LH should be asked directly about testosterone, prohormone, or anabolic steroid use.

Obesity is another frequent driver. In the EMAS cohort, BMI was the strongest single predictor of low LH and low testosterone in men, with each 1 kg/m² increase in BMI associated with a 2% decrease in total testosterone 12. Weight loss can partially restore LH pulsatility.

Pituitary tumors deserve attention. A prolactinoma suppresses GnRH pulses through hyperprolactinemia, producing low LH, low FSH, and low sex steroids. Prolactin should always be measured alongside LH when secondary hypogonadism is identified 8. Non-functioning pituitary adenomas can compress gonadotroph cells directly.

Other causes: hypothalamic amenorrhea from caloric restriction or excessive exercise in women, iron overload (hemochromatosis) affecting the pituitary, chronic opioid use, and congenital conditions like Kallmann syndrome (1 in 30,000 males) 15.

LH and the Primary vs. Secondary Hypogonadism Decision Tree

This single distinction drives nearly every treatment decision in hypogonadism management. Getting it right saves patients from inappropriate therapy.

If LH is high and testosterone is low: the testes are the problem. Testosterone replacement therapy (TRT) is the standard approach because the brain is already sending the correct signals. Clomiphene citrate will not meaningfully raise testosterone here, since the gonads cannot respond 3.

If LH is low and testosterone is low: the brain is the problem. Before starting TRT, the clinician should exclude reversible causes (obesity, opioid use, hyperprolactinemia, sleep apnea) and consider whether fertility preservation matters. In men who want to maintain spermatogenesis, clomiphene citrate (25 to 50 mg daily) or human chorionic gonadotropin (hCG) can raise LH activity and stimulate both testosterone and sperm production 16. The Endocrine Society guideline states: "In men with secondary hypogonadism who desire fertility, we suggest treatment with gonadotropins rather than testosterone" 3.

If LH is borderline and testosterone is low-normal: the picture is ambiguous. Repeat testing (two samples, both drawn before 10:00 AM) plus measurement of sex hormone-binding globulin (SHBG) and calculated free testosterone may clarify. An LH in the upper third of the reference range with a testosterone near the lower limit can represent compensated hypogonadism, an early stage where the pituitary is straining to maintain testosterone output 12.

How to Raise LH Levels

Low LH is not treated by targeting LH itself. Treatment addresses the underlying cause that suppressed the HPG axis.

Discontinue exogenous androgens. For men on testosterone or anabolic steroids, LH recovery after cessation typically takes 3 to 6 months, though recovery can be incomplete in those who used supraphysiologic doses for years 14. Clinicians sometimes bridge recovery with clomiphene or hCG to maintain testosterone levels while the axis restores itself.

Weight loss. In obese men, even a 10% reduction in body weight has been shown to raise total testosterone by 2 to 3 nmol/L and improve LH pulsatility 17. GLP-1 receptor agonists like semaglutide, which produce mean weight loss of 14.9% at 68 weeks in the STEP-1 trial (N=1,961), may also improve HPG axis signaling as an indirect benefit of fat mass reduction 18.

Treat hyperprolactinemia. Dopamine agonists (cabergoline 0.25 to 1 mg twice weekly) normalize prolactin and restore LH secretion in most prolactinoma cases 8.

Reduce opioid burden. Opioid-induced hypogonadism affects an estimated 35% to 85% of men on chronic opioid therapy 19. Dose reduction or rotation to partial agonists (buprenorphine) can improve LH and testosterone levels.

Optimize sleep and stress. Sleep deprivation suppresses GnRH pulsatility. One study showed that restricting sleep to 5 hours per night for one week reduced daytime testosterone by 10% to 15% in young healthy men 20.

How to Lower LH Levels

Elevated LH itself is usually a marker, not a target. The clinical goal is to treat the condition driving gonadal failure.

Testosterone replacement in primary hypogonadism. Exogenous testosterone suppresses GnRH and, consequently, LH. In men with confirmed primary hypogonadism and symptomatic low testosterone, TRT normalizes both testosterone levels and the elevated LH. Testosterone cypionate (100 to 200 mg intramuscularly every 1 to 2 weeks) or topical gels (1.62% testosterone gel, 40.5 to 81 mg daily) are first-line options per the Endocrine Society 3.

Hormone therapy in menopause. Combined estrogen-progestogen therapy in postmenopausal women partially suppresses elevated LH, though LH normalization is not a treatment target in menopausal HRT 7.

PCOS management. In women with PCOS and elevated LH, combined oral contraceptives suppress GnRH pulsatility, lower LH, and reduce androgen production. Weight loss in overweight PCOS patients also improves LH:FSH ratios 5.

An LH level that remains high after appropriate treatment may signal incomplete gonadal recovery or ongoing pathology that warrants repeat evaluation.

Practical Testing Considerations

Drawing LH correctly prevents misinterpretation. A few technical details matter more than most clinicians realize.

Timing. In men, draw between 7:00 and 10:00 AM to align with the testosterone diurnal peak. In premenopausal women, draw on cycle days 2 to 4 for baseline evaluation unless specifically testing for the midcycle surge 4.

Pulsatility. LH secretion is pulsatile with inter-pulse intervals of 60 to 120 minutes. A single sample may catch a trough. If results are borderline and clinical suspicion remains, repeat the draw or consider pooled samples (three draws 20 minutes apart, then combined) 1.

Assay variability. Different immunoassay platforms can yield LH values that differ by up to 20%. The World Health Organization international reference standard (WHO IS 80/552) helps standardize, but clinicians should use the same laboratory for serial monitoring 10.

Co-ordered labs. LH rarely provides a complete picture on its own. Pair it with FSH (gonadal reserve), total and free testosterone or estradiol (end-organ output), prolactin (pituitary screening), and SHBG (binding context). For fertility workups, add anti-Müllerian hormone (AMH) in women and semen analysis in men.

Medications that affect LH. GnRH agonists (leuprolide) initially spike then suppress LH. GnRH antagonists (degarelix) suppress LH immediately. Clomiphene and letrozole raise LH. Opioids, glucocorticoids, and exogenous sex steroids suppress it. Always document current medications before interpreting results.

Confirm abnormal results with at least one repeat sample before initiating treatment. One abnormal LH value is a finding. Two abnormal values on separate days are a diagnosis.

Frequently asked questions

What is a normal LH level?
Normal LH ranges vary by sex and context. For adult men, 1.8 to 8.6 IU/L is typical. Premenopausal women in the follicular phase range from 1.9 to 12.5 IU/L, while postmenopausal women typically measure 15.9 to 54.0 IU/L. Always interpret LH relative to menstrual cycle phase, age, and concurrent hormone levels.
What does a high LH mean?
High LH indicates the pituitary is compensating for low sex hormone production by the gonads. In men, it suggests primary testicular failure (Klinefelter syndrome, prior chemotherapy, orchitis). In premenopausal women, it may point to PCOS or premature ovarian insufficiency. In postmenopausal women, elevated LH is expected.
What does a low LH mean?
Low LH with low testosterone or estradiol signals secondary (central) hypogonadism. Common causes include exogenous testosterone or steroid use, obesity, pituitary tumors (especially prolactinomas), chronic opioid therapy, and hypothalamic amenorrhea from caloric restriction or overexercise.
When should LH be tested during the menstrual cycle?
For baseline fertility evaluation, LH is drawn on cycle days 2 to 4 (early follicular phase). For ovulation detection, serial testing begins around cycle day 10 to identify the midcycle LH surge, which precedes ovulation by 24 to 36 hours.
What is the LH to FSH ratio, and why does it matter?
An LH:FSH ratio greater than 2:1 measured on cycle day 3 raises suspicion for PCOS, though it is not required for diagnosis under the Rotterdam criteria. In men, a disproportionately elevated FSH with normal LH may indicate isolated Sertoli cell dysfunction rather than global testicular failure.
Can LH levels predict ovulation?
Yes. The midcycle LH surge (a rapid rise to 2 to 3 times baseline) reliably predicts ovulation within 24 to 36 hours. Home ovulation predictor kits detect this surge in urine. Serum LH measurement provides more precise quantification when clinical timing is critical, such as during IUI cycles.
Does testosterone therapy affect LH?
Exogenous testosterone suppresses GnRH from the hypothalamus, which drops LH to very low levels (often below 0.5 IU/L). This suppresses spermatogenesis. Men on TRT who want to preserve fertility should discuss alternatives like clomiphene or hCG with their clinician.
Should I fast before an LH blood test?
Fasting is not required for an LH test. The main timing consideration is drawing the sample in the early morning (7:00 to 10:00 AM) for men and on the correct cycle day for premenopausal women. Avoid testing during acute illness, which can transiently suppress the HPG axis.
How often should LH be rechecked?
After an initial abnormal result, repeat LH within 2 to 4 weeks to confirm. Once a diagnosis is established and treatment started, recheck LH at 3 months to assess response. For men on TRT, annual LH monitoring is not typically needed because exogenous testosterone predictably suppresses it.
Can stress affect LH levels?
Yes. Acute psychological or physiological stress activates the hypothalamic-pituitary-adrenal (HPA) axis, which suppresses GnRH pulsatility and lowers LH. Chronic stress, caloric restriction, and overtraining all reduce LH through the same mechanism. This is the basis of hypothalamic amenorrhea in athletes.
What medications can raise LH?
Clomiphene citrate and letrozole block estrogen feedback at the hypothalamus, increasing GnRH pulses and raising LH. Anti-androgens like flutamide can also raise LH. GnRH agonists (leuprolide) cause an initial LH flare before suppression. Always note current medications before interpreting LH results.
Is LH testing covered by insurance?
Most insurers cover LH testing when ordered for a documented clinical indication such as infertility evaluation, hypogonadism workup, or suspected pituitary pathology. Without insurance, the test costs approximately $30 to $75 at commercial laboratories.

References

  1. Stamatiades GA, Kaiser UB. Gonadotropin regulation by pulsatile GnRH: signaling and gene expression. Mol Cell Endocrinol. 2018;463:131-141. https://pubmed.ncbi.nlm.nih.gov/24830959/
  2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  3. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2021;116(2):231-253. https://pubmed.ncbi.nlm.nih.gov/34246871/
  4. Goodman NF, Cobin RH, Futterweit W, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review. Endocr Pract. 2015;21(12):1291-1300. https://pubmed.ncbi.nlm.nih.gov/30445145/
  5. Roos J, Johnson S, Weddell S, et al. Monitoring the menstrual cycle: comparison of urinary and serum reproductive hormones referenced to true ovulation. Eur J Contracept Reprod Health Care. 2015;20(6):438-450. https://pubmed.ncbi.nlm.nih.gov/29518047/
  6. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/34546940/
  7. Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888-3921. https://pubmed.ncbi.nlm.nih.gov/27178892/
  8. Latronico AC, Brito VN, Carel JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol. 2016;4(3):265-274. https://pubmed.ncbi.nlm.nih.gov/30926834/
  9. Bhasin S, Brito JP, Cunningham GR, et al. Reference ranges for testosterone, LH, and FSH. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  10. Groth KA, Skakkebæk A, Høst C, et al. Klinefelter syndrome: a clinical update. J Clin Endocrinol Metab. 2013;98(1):20-30. https://pubmed.ncbi.nlm.nih.gov/28981163/
  11. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123-135. https://pubmed.ncbi.nlm.nih.gov/20173018/
  12. European Society of Human Reproduction and Embryology. Management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-937. https://pubmed.ncbi.nlm.nih.gov/26858544/
  13. de Ronde W, Smit DL. Anabolic-androgenic steroid abuse and hypogonadism: detection, treatment, and outcomes. Curr Opin Endocrinol Diabetes Obes. 2020;27(3):187-193. https://pubmed.ncbi.nlm.nih.gov/31180539/
  14. Boehm U, Bouloux PM, Dattani MT, et al. Congenital hypogonadotropic hypogonadism and Kallmann syndrome: pathogenesis, genetics, and treatment. Endocr Rev. 2015;36(5):465-491. https://pubmed.ncbi.nlm.nih.gov/26740230/
  15. Wheeler KM, Sharma D, Kavoussi PK, et al. Clomiphene citrate for the treatment of hypogonadism. Sex Med Rev. 2019;7(2):272-276. https://pubmed.ncbi.nlm.nih.gov/31368633/
  16. Corona G, Rastrelli G, Morelli A, et al. Treatment of functional hypogonadism besides pharmacological substitution. World J Mens Health. 2020;38(3):256-270. https://pubmed.ncbi.nlm.nih.gov/31338775/
  17. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP-1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  18. Rubinstein A, Carpenter DM. Elucidating risk factors for androgen deficiency associated with daily opioid use. Am J Med. 2014;127(12):1195-1201. https://pubmed.ncbi.nlm.nih.gov/25318580/
  19. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305(21):2173-2174. https://pubmed.ncbi.nlm.nih.gov/21632481/